Rialto Wealth Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.7K Sell
95
-5
-5% -$1.85K 0.01% 353
2026
Q1
$29.3K Buy
100
+62
+163% +$20.4K 0.01% 333
2025
Q4
$13.3K Buy
38
+2
+6% +$676 ﹤0.01% 415
2025
Q3
$11.6K Hold
36
﹤0.01% 409
2025
Q2
$14K Buy
36
+5
+16% +$2.01K ﹤0.01% 386
2025
Q1
$13.5K Buy
+31
New +$12.4K ﹤0.01% 381

Other funds holding ELV

Rialto Wealth Management's ELV Position: Q2 2026 in Review

Rialto Wealth Management reduced its Elevance Health (ELV) stake by 5% in Q2 2026, selling an estimated $1.85K and leaving 95 shares worth $36.7K. The position accounts for 0.01% of the portfolio, ranked #353.

Rialto Wealth Management first reported a position in ELV in Q1 2025 and has held it in 6 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Rialto Wealth Management held 95 shares of Elevance Health worth $36.7K as of Q2 2026.
  • Rialto Wealth Management sold 5 Elevance Health shares in Q2 2026, an estimated $1.85K.
  • Elevance Health made up 0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #353 holding.
  • Rialto Wealth Management first reported a position in Elevance Health in Q1 2025 and has held it in 6 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.